The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Acute Myocardial Infarction in Cancer Patients
Official Title: Risk and Clinical Outcomes of Acute Myocardial Infarction in Patients With Cancer: A Nationwide Study
Study ID: NCT06281054
Brief Summary: Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis.
Detailed Description: This study will be conducted using Korean National Health Insurance Service database. Patients who were diagnosed with cancer from 2002 to 2021 will be included in the study. Using the selected patients, current study will analyze the incidence and prognosis of acute myocardial infarction in cancer patients and the prognosis according to the treatment method for acute myocardial infarction will be compared. Primary outcome will be all-cause death. Secondary outcomes will be myocardial infarction, revascularization, hospitalization for heart failure, stroke, and clinically relevant bleeding.
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, , Korea, Republic of
Name: Joo Myung Lee, MD, MPH, PhD
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Seung Hun Lee, MD, PhD
Affiliation: Chonnam National University Hospital
Role: PRINCIPAL_INVESTIGATOR